These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31245879)

  • 21. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
    Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
    Bruin-Weller M; Pink AE; Patrizi A; Gimenez-Arnau AM; Agner T; Roquet-Gravy PP; Ferrucci SM; Arenberger P; Svensson A; Schuttelaar MLA; Nosbaum A; Jayawardena S; Rizova E; Ardeleanu M; Eckert L; Ozturk ZE
    J Dermatolog Treat; 2021 Mar; 32(2):164-173. PubMed ID: 33461356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.
    Arima K; Gupta S; Gadkari A; Hiragun T; Kono T; Katayama I; Demiya S; Eckert L
    J Dermatol; 2018 Apr; 45(4):390-396. PubMed ID: 29388334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
    Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [No Abstract]   [Full Text] [Related]  

  • 26. Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.
    Exposto F; Hermans R; Nordgren Å; Taylor L; Sikander Rehman S; Ogley R; Davies E; Yesufu-Udechuku A; Beaudet A
    Ther Adv Respir Dis; 2021; 15():1753466621995040. PubMed ID: 33620026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
    Bell CF; Priest J; Stott-Miller M; Kan H; Amelio J; Song X; Limone B; Noxon V; Costenbader KH
    Lupus Sci Med; 2020; 7(1):e000357. PubMed ID: 32341790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
    Toro W; Yang M; Georgieva M; Song W; Patel A; Jiang AX; Zhao A; LaMarca N; Dabbous O
    Adv Ther; 2023 Oct; 40(10):4589-4605. PubMed ID: 37587305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world treatment patterns for atopic dermatitis in South Korea.
    Lee JH; Choi A; Noh Y; Oh IS; Jeon JY; Yoo HJ; Shin JY; Son SW
    Sci Rep; 2022 Aug; 12(1):13626. PubMed ID: 35948589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database.
    Weil C; Sugerman PB; Chodick G; Liang H; Wang H; Calimlim BM; Dorfman A; Shalev V; Ben Amitai D; Leshem YA
    Adv Ther; 2022 Jun; 39(6):2502-2514. PubMed ID: 35352308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of atopic dermatitis in the Netherlands: an international comparison.
    Verboom P; Hakkaart-Van L; Sturkenboom M; De Zeeuw R; Menke H; Rutten F
    Br J Dermatol; 2002 Oct; 147(4):716-24. PubMed ID: 12366418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
    Bell CF; Blauer-Peterson C; Mao J
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1249-1259. PubMed ID: 34165321
    [No Abstract]   [Full Text] [Related]  

  • 34. An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis.
    Salo H; Pekurinen M; Granlund H; Nuutinen M; Erkko P; Reitamo S
    Acta Derm Venereol; 2004; 84(2):138-41. PubMed ID: 15206694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis.
    Armstrong AW; Huang A; Wang L; Miao R; Patel MY; Gadkari A; Mallya UG; Chao J
    PLoS One; 2019; 14(1):e0210517. PubMed ID: 30682042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atopic dermatitis: phototherapy and systemic therapy.
    Davis DM; Borok J; Udkoff J; Lio P; Spergel J
    Semin Cutan Med Surg; 2017 Sep; 36(3):118-123. PubMed ID: 28895958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.
    McPherson T; Cork MJ; Goodhead C; Michaelis LJ; Flohr C; Petrovic M; Hennessy L; Rajkovic I; Hudson R
    Pediatr Dermatol; 2023 Jan; 40(1):50-63. PubMed ID: 36127813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data.
    Nazareth TA; Kariburyo F; Kirkemo A; Xie L; Pavlova-Wolf A; Bartels-Peculis L; Vaidya N; Sim JJ
    J Manag Care Spec Pharm; 2019 Sep; 25(9):1011-1020. PubMed ID: 31283419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.